
    
      The TRACE is a multicenter, registry observational study. Xingnaojing injection is the only
      essential traditional chinese medicine on emergency ambulance used for acute stroke.The
      primary hypothesis of this trial is that Xingnaojing used for acute stroke within 24 hours of
      symptom onset on ambulance will improve the Early neurological deterioration of acute stroke
      at 3 days. All suspected acute stroke participants will be registered once they are taken on
      the ambulance. The primary outcome will be determined at 3 days.Besides, there will be a
      quantitative interview with emergency doctors about their knowledge and attitude on
      Xingnaojing for acute stroke patients.
    
  